Total planned funding: $190,201,136
Allocations
Countries/Regions
India | $190,201,136 |
Organizational Types
Unknown | $85,348,336 |
NGO | $51,909,099 |
Own Agency | $28,139,009 |
University | $15,932,112 |
Private Contractor | $3,348,272 |
Multi-lateral Agency | $2,856,808 |
FBO | $1,100,000 |
Host Country Government Agency | $940,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $70,769,579 |
Prevention | $48,194,799 |
Care | $25,388,983 |
Management and Operations | $21,107,742 |
Testing | $10,986,010 |
Treatment | $9,326,231 |
Budget Codes
OHSS: Health Systems Strengthening | $41,334,420 |
HVOP: Sexual Prevention: Other Sexual Prevention | $25,083,152 |
HVSI: Strategic Information | $24,235,737 |
HVMS: Management and Operations | $21,107,742 |
HBHC: Care: Adult Care and Support | $17,510,469 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,260,149 |
HVCT: Testing: HIV Testing and Counseling | $10,986,010 |
HTXS: Treatment: Adult Treatment | $8,990,960 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,921,776 |
HLAB: Laboratory Infrastructure | $5,199,422 |
HKID: Care: Orphans and Vulnerable Children | $5,029,014 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,405,455 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,368,193 |
PDCS: Care: Pediatric Care and Support | $481,307 |
PDTX: Treatment: Pediatric Treatment | $311,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$84,723,847
Countries/Regions
FHI 360:
$17,891,011
Countries/Regions
USG Aggregated Agencies:
$14,996,527
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions